Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 2077-2085

  Lee, Kuei Chuan ^a,b   Yang, Ying Ying ^a,b   Wang, Ying Wen ^a,b   Lee, Fa Yauh ^a,b   Loong, Che Chuan ^a,b   Hou, Ming Chih ^a,b   Lin, Han Chieh ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Endotoxin; Malondialdehyde; Nitric oxide; Portal hypertension; Superoxide dismutase

Indexed keywords

BILIRUBIN; ENDOTOXIN; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENDOTOXINS; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PORTAL PRESSURE; REFERENCE VALUES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 77954425029     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0990-2     Document Type: Article

References (43)

1. V Adam-Vizi C Chinopoulos 2006 Bioenergetics and the formation of mitochondrial reactive oxygen species Trends Pharmacol Sci 27 639 645 10.1016/j.tips.2006.10.005 1:CAS:528:DC%2BD28Xht1eku7fF 17056127 (Pubitemid 44767940)
2. AC Cave AC Brewer A Narayanapanicker, et al. 2006 NADPH oxidases in cardiovascular health and disease Antioxid Redox Signal 8 691 728 10.1089/ars.2006.8.691 1:CAS:528:DC%2BD28XlsFOntb8%3D 16771662 (Pubitemid 44043102)
3. D Wu AI Cederbaum 2003 Alcohol, oxidative stress, and free radical damage Alcohol Res Health 27 277 284 15540798
4. A Rodriguez-Vilarrupla J Bosch JC Garcia-Pagan 2007 Potential role of antioxidants in the treatment of portal hypertension J Hepatol 46 193 197 10.1016/j.jhep.2006.11.008 1:CAS:528:DC%2BD2sXhslymsQ%3D%3D 17161493 (Pubitemid 46001474)
5. E Cadenas 1989 Biochemistry of oxygen toxicity Annu Rev Biochem 58 79 110 10.1146/annurev.bi.58.070189.000455 1:CAS:528:DyaL1MXltFSgtL8%3D 2673022
6. J Bosch JC Garcia-Pagan 2000 Complications of cirrhosis. I. Portal hypertension J Hepatol 32 141 156 10.1016/S0168-8278(00)80422-5 1:CAS:528:DC%2BD3cXkslylsbs%3D 10728801
7. M Parola G Robino 2001 Oxidative stress-related molecules and liver fibrosis J Hepatol 35 297 306 10.1016/S0168-8278(01)00142-8 1:CAS:528: DC%2BD3MXntFKhtL4%3D 11580156 (Pubitemid 32803489)
8. R Marley S Holt B Fernando, et al. 1999 Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis Hepatology 29 1358 1363 10.1002/hep.510290519 1:CAS:528:DyaK1MXjt1Wnuro%3D 10216116 (Pubitemid 29211034)
9. B Fernando R Marley S Holt, et al. 1998 N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat Hepatology 28 689 694 10.1002/hep.510280314 1:CAS:528:DyaK1cXlvVyit7k%3D 9731560
10. YY Yang KC Lee YT Huang, et al. 2008 Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis J Hepatol 49 25 33 10.1016/j.jhep.2008.02.012 1:CAS:528:DC%2BD1cXmvFels7o%3D 18490076
11. M Hernandez-Guerra JC Garcia-Pagan J Turnes, et al. 2006 Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension Hepatology 43 485 491 10.1002/hep.21080 1:CAS:528:DC%2BD28XjtVKqsbs%3D 16496307
12. A Aboutwerat PW Pemberton A Smith, et al. 2003 Oxidant stress is a significant feature of primary biliary cirrhosis Biochim Biophys Acta 1637 142 150 1:CAS:528:DC%2BD3sXhvFeqtL4%3D 12633902
13. G Nalini C Hariprasad VA Narayanan 1999 Oxidative stress in alcoholic liver disease Indian J Med Res 110 200 203 1:STN:280:DC%2BD3c7ms1WhtQ%3D%3D 10701300
14. SK Jain PW Pemberton A Smith, et al. 2002 Oxidative stress in chronic hepatitis C: Not just a feature of late stage disease J Hepatol 36 805 811 10.1016/S0168-8278(02)00060-0 1:CAS:528:DC%2BD38XktVCktLY%3D 12044532 (Pubitemid 35177411)
15. P Clot M Tabone S Arico E Albano 1994 Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake Gut 35 1637 1643 10.1136/gut.35.11.1637 1:STN:280:DyaK2M7ivF2ktA%3D%3D 7828989
16. J Goulis D Patch AK Burroughs 1999 Bacterial infection in the pathogenesis of variceal bleeding Lancet 353 139 142 10.1016/S0140-6736(98) 06020-6 1:STN:280:DyaK1M7ks1Ghsw%3D%3D 10023916 (Pubitemid 29088094)
17. C Guarner G Soriano A Tomas, et al. 1993 Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia Hepatology 18 1139 1143 10.1002/hep.1840180520 1:STN:280:DyaK2c%2FktFWquw%3D%3D 8225220
18. Y Iwakiri RJ Groszmann 2006 The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule Hepatology 43 S121 S131 10.1002/hep.20993 1:CAS:528:DC%2BD28XhvVSktLY%3D 16447289
19. YW Wang TI Hou YY Yang, et al. 2007 Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium or outcome prediction in patients with liver cirrhosis J Clin Gastroenterol 41 706 712 10.1097/MCG.0b013e31802dabb3 17667056 (Pubitemid 47220477)
20. P Gines A Cardenas V Arroyo J Rodes 2004 Management of cirrhosis and ascites N Engl J Med 350 1646 1654 10.1056/NEJMra035021 1:CAS:528: DC%2BD2cXjt1WksLg%3D 15084697 (Pubitemid 38501166)
21. HC Lin YT Tsai FY Lee, et al. 1992 Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis Gastroenterology 103 229 234 1:STN:280:DyaK38zgslaqug%3D%3D 1612330
22. Z Yesilova H Yaman C Oktenli, et al. 2005 Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease Am J Gastroenterol 100 850 855 10.1111/j.1572-0241.2005.41500.x 1:CAS:528:DC%2BD2MXktFart74%3D 15784031 (Pubitemid 40592378)
23. S Moncada A Higgs 1993 The l-arginine-nitric oxide pathway N Engl J Med 329 2002 2012 10.1056/NEJM199312303292706 1:CAS:528:DyaK2cXhsF2ntrw%3D 7504210 (Pubitemid 24015045)
24. Y Toh D Korenaga S Maekawa, et al. 1997 Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein Hepatogastroenterology 44 1147 1151 1:CAS:528:DyaK2sXls1ektL8%3D 9261615
25. A Ramachandran R Prabhu S Thomas JB Reddy A Pulimood KA Balasubramanian 2002 Intestinal mucosal alterations in experimental cirrhosis in the rat: Role of oxygen free radicals Hepatology 35 622 629 10.1053/jhep.2002.31656 1:CAS:528:DC%2BD38Xitlyqsbg%3D 11870376 (Pubitemid 34183967)
26. G Schimpl P Pesendorfer G Steinwender G Feierl M Ratschek ME Hollwarth 1996 Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats Gut 39 48 53 10.1136/gut.39.1.48 1:CAS:528:DyaK28XkvFertrY%3D 8881808
27. T Yoshikawa H Takano S Takahashi H Ichikawa M Kondo 1994 Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure Circ Shock 42 53 58 1:CAS:528:DyaK2cXis1Ojtb0%3D 8149510
28. MT Portoles MJ Ainaga R Pagani 1993 The induction of lipid peroxidation by E. coli lipopolysaccharide on rat hepatocytes as an important factor in the etiology of endotoxic liver damage Biochim Biophys Acta 1158 287 292 1:CAS:528:DyaK2cXnsVGhtw%3D%3D 8251529
29. S Dogru-Abbasoglu H Parildar-Karpuzoglu J Balkan G Aykac-Toker M Uysal 2007 Nitrotyrosine formation and heme oxygenase-1 expression in endotoxemic cirrhotic rats Arch Med Res 38 28 33 10.1016/j.arcmed.2006.07.003 1:CAS:528:DC%2BD28XhtlaktLjL 17174719 (Pubitemid 44894611)
30. RE Huie S Padmaja 1993 The reaction of NO with superoxide Free Radic Res Commun 18 195 199 10.3109/10715769309145868 1:CAS:528:DyaK3sXmsVeit74%3D 8396550
31. R Radi JS Beckman KM Bush BA Freeman 1991 Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide Arch Biochem Biophys 288 481 487 10.1016/0003-9861(91)90224-7 1:CAS:528: DyaK3MXksVertrY%3D 1654835
32. MA Rodriguez-Martinez J Martinez-Orgado M Salaices J Marin 1996 Impairment of acetylcholine relaxations by malondialdehyde, a marker of lipid peroxidation J Vasc Res 33 463 470 1:CAS:528:DyaK2sXltlegug%3D%3D 8998195
33. M Parola G Leonarduzzi G Robino E Albano G Poli MU Dianzani 1996 On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis Free Radic Biol Med 20 351 359 10.1016/0891-5849(96) 02055-2 1:CAS:528:DyaK28XhvVWitrY%3D 8720905 (Pubitemid 26077857)
34. 2 production from Kupffer cells of the prefibrotic rat liver J Hepatol 46 276 285 10.1016/j.jhep.2006.08.026 1:CAS:528:DC%2BD2sXhslylsQ%3D%3D 17161492 (Pubitemid 44959165)
35. DC Rockey RA Weisiger 1996 Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance Hepatology 24 233 240 10.1002/hep.510240137 1:CAS:528:DyaK28XkvFSju7s%3D 8707268
36. G Bianchi G Marchesini A Fabbri M Ronchi R Chianese G Grossi 1997 Lipoperoxide plasma levels in patients with liver cirrhosis Hepatogastroenterology 44 784 788 1:STN:280:DyaK2szmsFylsQ%3D%3D 9222690 (Pubitemid 27281118)
37. F Trevisani P Caraceni M Simoncini, et al. 2002 Evidence of oxidative imbalance in long-term liver transplant patients Dig Liver Dis 34 279 284 10.1016/S1590-8658(02)80148-7 1:CAS:528:DC%2BD38XktlSisL8%3D 12038812 (Pubitemid 34461061)
38. Y Yamamoto S Yamashita A Fujisawa S Kokura T Yoshikawa 1998 Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants Biochem Biophys Res Commun 247 166 170 10.1006/bbrc.1998.8752 1:CAS:528:DyaK1cXjvVSht7c%3D 9636673 (Pubitemid 28412544)
39. V Paradis P Mathurin M Kollinger, et al. 1997 In situ detection of lipid peroxidation in chronic hepatitis C: Correlation with pathological features J Clin Pathol 50 401 406 10.1136/jcp.50.5.401 1:STN:280:DyaK2szlsl2nsA%3D%3D 9215123 (Pubitemid 27278444)
40. D Schuppan NH Afdhal 2008 Liver cirrhosis Lancet 371 838 851 10.1016/S0140-6736(08)60383-9 1:CAS:528:DC%2BD1cXivFyqur4%3D 18328931 (Pubitemid 351323895)
41. A Szuster-Ciesielska J Daniluk M Kandefer-Szerszen 2002 Oxidative stress in the blood of patients with alcohol-related liver cirrhosis Med Sci Monit 8 CR419 CR424 12070432
42. T Matoba H Shimokawa H Kubota, et al. 2002 Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries Biochem Biophys Res Commun 290 909 913 10.1006/bbrc.2001.6278 1:CAS:528: DC%2BD38XksVyrtw%3D%3D 11798159 (Pubitemid 34687447)
43. J Bauersachs R Popp M Hecker E Sauer I Fleming R Busse 1996 Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor Circulation 94 3341 3347 1:CAS:528:DyaK2sXkslSjtA%3D%3D 8989149